EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of 25‐Hydroxyvitamin D With Metabolic Dysfunction‐Associated Fatty Liver Disease: Results From NHANES 2017–2018

Xiaojuan Rao, Xinxin Zhang iD, Shuo Li, Bo Huang, Junhe Wang, Jingqiu Cui iD, Ming Liu iD, Tiekun Yan iD

International Journal of Endocrinology · 2025-01 · 2025 (1)

DOI: 10.1155/ije/1368301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Endocrinology, online erschienen am 23.09.2025. Verfasst von Xiaojuan Rao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Tianjin Municipal Education Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The association of vitamin D with metabolic dysfunction‐associated fatty liver disease (MAFLD) remained unclear. This study aimed to examine the relationships of total 25‐hydroxyvitamin D [25(OH)D, the sum of 25(OH)D 2 and 25(OH)D 3 ], 25(OH)D 3 , and epi‐25(OH)D 3 with MAFLD.

Methods

We used the National Health and Nutrition Examination Survey of the 2017–2018 cycle for our present analysis. Binary logistic regression analyses were conducted to explore the associations of total 25(OH)D, 25(OH)D 3 , and epi‐25(OH)D 3 with MAFLD after adjusting for confounders. Interaction tests were conducted to compare the association between 25(OH)D and MAFLD in subgroups.

Results

The final analysis included 4605 subjects. After adjustment for confounders, the odds of MAFLD decreased with increasing concentrations of total 25(OH)D (odds ratio [OR], 0.45; 95% confidence interval [CI], 0.29–0.68; p for trend < 0.001). Serum 25(OH)D 3 showed a strong inverse association with MAFLD (OR, 0.39; 95% CI, 0.25–0.59; p for trend < 0.001). In addition, participants with lower epi‐25(OH)D 3 levels had a higher likelihood of MAFLD, as demonstrated in both quartile and continuous models (OR, 0.77; 95% CI, 0.60–0.99; p = 0.041). After stratification by lipid status, inverse associations of total 25(OH)D and 25(OH)D 3 with MAFLD were found only in dyslipidemic participants ( p for interaction < 0.001). A sex‐specific interaction was also noted for 25(OH)D 3 , showing stronger effects in women than in men ( p = 0.036).

Conclusions

Low serum total 25(OH)D, 25(OH)D 3 , and epi‐25(OH)D 3 were significantly associated with a higher prevalence of MAFLD. These associations showed nonlinear patterns and were particularly evident among participants with dyslipidemia, with 25(OH)D 3 demonstrating stronger protective effects in women than in men. Given the cross‐sectional design, causality cannot be inferred, and further prospective studies are required to confirm these findings.

Schlagwörter

Stichwörter der Autor:innen

25-Hydroxyvitamin D25-Hydroxyvitamin D3National Health and Nutrition Examination Surveymetabolic dysfunction-associated fatty liver disease

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.
  • Department of Nephrology, Kidney Disease Medical Center, National Key Clinical Specialty, Tianjin Key Medical Discipline, Tianjin Medical University General Hospital, Tianjin, China.

ORCID-Profile: Xinxin Zhang, Jingqiu Cui, Ming Liu, Tiekun Yan

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Tianjin Municipal Education Commission

Zitieren

APA

Rao, X., Zhang, X., Li, S., Huang, B., Wang, J., Cui, J., Liu, M., & Yan, T. (2025). Association of 25‐Hydroxyvitamin D With Metabolic Dysfunction‐Associated Fatty Liver Disease: Results From NHANES 2017–2018. International Journal of Endocrinology, 2025(1). https://doi.org/10.1155/ije/1368301

Vancouver

Rao X, Zhang X, Li S, Huang B, Wang J, Cui J, et al. Association of 25‐Hydroxyvitamin D With Metabolic Dysfunction‐Associated Fatty Liver Disease: Results From NHANES 2017–2018. International Journal of Endocrinology. 2025;2025(1). doi:10.1155/ije/1368301

BibTeX
@article{Rao2025,
  author = {Rao, Xiaojuan and Zhang, Xinxin and Li, Shuo and Huang, Bo and Wang, Junhe and Cui, Jingqiu and Liu, Ming and Yan, Tiekun},
  title = {Association of 25‐Hydroxyvitamin D With Metabolic Dysfunction‐Associated Fatty Liver Disease: Results From NHANES 2017–2018},
  journal = {International Journal of Endocrinology},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/ije/1368301}
}
Kostenlos starten →